[{"Assets_0_Q3_USD":161657736.0,"CommonStockSharesOutstanding_0_Q3_shares":38672216.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-12886060.0,"NetIncomeLoss_1_Q3_USD":-4101628.0,"NetIncomeLoss_3_Q3_USD":-17167486.0,"StockholdersEquity_0_Q3_USD":149479427.0,"Ticker":"AXGN","CIK":"805928","name":"AXOGEN, INC.","OfficialName":"Axogen Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"313567338.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20181029"}]